Skip to main content
NCBI home page
Research and Practice in Thrombosis and Haemostasis logoLink to Research and Practice in Thrombosis and Haemostasis
. 2020 Jan 20;4(2):347. doi: 10.1002/rth2.12304

Corrigendum

PMCID: PMC7040531  PMID: 32110767

In the article by Chowdary et al,1 Figure 3C was incorrectly published. The correct figure is shown below:

graphic file with name RTH2-4-347-g001.jpg

REFERENCE

  • 1. Chowdary P, Carcao M, Holme PA, Jiménez‐Yuste V, Lentz SR, Møss J, et al. Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A. Res Pract Thromb Haemost. 2019;3(3):542–54. 10.1002/rth2.12220. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Research and Practice in Thrombosis and Haemostasis are provided here courtesy of Elsevier

RESOURCES